the short answer
BPC-157 is a synthetic peptide studied in preclinical models for tissue repair, gut lining, and blood flow. There are no completed controlled canine trials for the uses owners care about, and it is not an FDA-approved drug for dogs. The evidence is promising and incomplete.
What it is
BPC-157 is a 15-amino-acid peptide derived from a gastric protein. In animal models it has been studied for tendon, ligament, gut, and wound repair. The mechanism is not fully understood.
What the research shows
Most of the evidence is rodent and in-vitro work. Reviews describe accelerated healing and anti-inflammatory effects in those models. That is not the same as a controlled trial in dogs with arthritis or a torn ligament.
What it does not show
No controlled canine trial has established a dose, a benefit, or long-term safety for the uses owners ask about. There is no FDA approval for canine use. Anyone who says otherwise is ahead of the evidence.
How to talk to your vet
Bring the batch certificate, the ingredient list, and this page. Ask about interactions, the dog’s other conditions, and whether a daily injectable is appropriate. The decision is theirs.
Questions owners ask
Is BPC-157 FDA-approved for dogs?
No. It is not an FDA-approved veterinary drug, and no controlled canine trials have been completed.
Is BPC-157 safe for dogs?
Preclinical toxicology is reassuring, but long-term canine safety is not established. Ask your vet, especially if the dog is on medication or has cancer.
How long until it works?
We do not promise a timeline. The honest window is weeks, not days, and the response varies.